NCT04631913 is a clinical trial in Healthy, sponsored by University of Toronto.

Who is sponsoring NCT04631913?

NCT04631913 is sponsored by University of Toronto.

What condition does NCT04631913 study?

NCT04631913 studies Healthy, Diabetes, Metabolic Syndrome, Overweight and Obesity.

Is NCT04631913 still recruiting?

NCT04631913 is currently status unknown. Last updated 17 November 2020.

Last reviewed 2020-11-17 · How we verify

NCT04631913

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Meta-analysis of Oats for Diabetes Prevention and Management

Status unknown Last updated 17 November 2020

What this trial tests

trial in Healthy in 1 participant. Status unknown.

Timeline

14 August 2020

Primary endpoint
31 July 2021

30 November 2021

Quick facts

Lead sponsor	University of Toronto
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1
Start date	14 August 2020
Primary completion	31 July 2021
Estimated completion	30 November 2021
Sites	1 location across Canada

Conditions studied

Healthy — all drugs for Healthy →
Diabetes — all drugs for Diabetes →
Metabolic Syndrome — all drugs for Metabolic Syndrome →
Overweight and Obesity — all drugs for Overweight and Obesity →

Sponsor

University of Toronto

Who can join

18 and older, any sex, with Healthy or Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Oats are a commonly consumed source of viscous soluble fibre, which has an established role in cardiovascular disease risk management including in cholesterol and glycemic control. Oat beta-glucan is recognized for its cholesterol-lowering effects with approved health claims in Canada, US and Europe. However, the efficacy of oat beta-glucan on glycemic control is not clear. We propose to conduct a systematic review and meta-analysis to explore the efficacy of whole grain oats and oat beta-glucan on markers of glycemic control in people with, without or at risk for diabetes.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effect of oats and oat ß-glucan on glycemic control in diabetes: a systematic review and meta-analysis of randomized controlled trials
Chen V, Zurbau A, Ahmed A, Khan T, et al · · 2022
Effect of Oats and Oat-Fiber on Glycemic Control in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
· 2021

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other University of Toronto trials

Trials by the same sponsor.

NCT07184255 — Animated Video Education for Retinal Surgery · NA · not yet recruiting
NCT07259434 — Time Restricted Eating in Survivors Trial 2.0 · NA · not yet recruiting
NCT07486050 — The Impact of Social Worker Referrals on Diabetes and Loneliness · NA · active not recruiting
NCT07268729 — Investigation of Pathogenic Gut Microbiota Patterns in Anxiety, Depression and Panic Disorders · not yet recruiting
NCT07317921 — Validating IAAO for Muscle Outcomes · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04631913 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Toronto
Last refreshed: 17 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04631913.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing